id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-E-0279-0003,FDA,FDA-2014-E-0279,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2014-03-27T04:00:00Z,2014,3,2014-03-27T04:00:00Z,,2014-03-27T14:58:30Z,,0,0,0900006481686bb3
FDA-2014-E-0279-0001,FDA,FDA-2014-E-0279,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2014-03-06T05:00:00Z,2014,3,2014-03-06T05:00:00Z,,2014-03-06T15:04:36Z,,0,0,0900006481605dc8
FDA-2014-E-0279-0002,FDA,FDA-2014-E-0279,"Patent Extension from Fitzpatrick, Cella, Harper & Scinto (Bristol-Myers Squibb Company)",Other,Application,2014-03-06T05:00:00Z,2014,3,2014-03-06T05:00:00Z,,2014-03-06T15:04:57Z,,0,0,0900006481605dc7